Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 301 - 320 of 490 trials
Titlesort icon Investigator Disease(s)
A Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide
[Protocol 11-003]
Rimner, Andreas
  • Lung Cancer
  • Lung Cancer, Small Cell
    • Other
A Phase III Randomized Study of Concurrent Chemotherapy and Pelvic Radiation Therapy with or without Adjuvant Chemotherapy in High-Risk Patients with Early-Stage Cervical Cancer Following Radical Hysterectomy
[Protocol 10-173]
Leitao, Mario
  • Cervical Cancer
A Phase III Randomized Study of Expanded Umbilical Cord Blood Cells to Enhance Blood System Recovery in Patients with Hematologic Cancers Undergoing Stem Cell Transplantation
[Protocol 13-214]
Barker, Juliet
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
A Phase III Study Assessing Chemoradiation Alone and with Additional Chemotherapy in Women with Locally Advanced, Inoperable Cervical Cancer: The OUTBACK Trial
[Protocol 12-171]
Leitao, Mario
  • Cervical Cancer
A Phase III Study Comparing Mometasone Furoate with Eucerin to Treat Radiation-Related Skin Redness and Peeling in Breast Cancer Patients after Mastectomy
[Protocol 13-069]
Olm-Shipman, Molly
  • Breast Cancer
A Phase III Study Comparing Standard versus Extended Pelvic Lymph Node Removal During Bladder Cancer Surgery
[Protocol 12-049]
Bochner, Bernard
  • Bladder Cancer
A Phase III Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy in Patients with Metastatic Cancer
[Protocol 10-154]
Zelefsky, Michael
A Phase III Study Evaluating the Addition of Trastuzumab to Standard Therapy for HER2-Positive Esophageal Cancers
[Protocol 12-094]
Wu, Abraham
  • Upper Gastrointestinal
    • Esophageal Cancer
A Phase III Study of Accelerated Whole Breast Radiation Therapy with a Boost versus Standard Whole Breast Radiation with a Boost in Women with Early-Stage Breast Cancer (RTOG 1005)
[Protocol 12-158]
Parhar, Preeti
  • Breast Cancer
A Phase III Study of Actinomycin-D versus Methotrexate to Treat Low-Risk Gestational Trophoblastic Disease
[Protocol 13-108]
Jewell, Elizabeth
  • Uterine (Endometrial) Cancer
A Phase III Study of AEZS-108 versus Doxorubicin as Second-Line Therapy for Recurrent or Metastatic Endometrial Cancer
[Protocol 13-130]
Konner, Jason
  • Uterine (Endometrial) Cancer
A Phase III Study of Alisertib versus Standard Therapy in Patients with Recurrent or Persistent Peripheral T-Cell Lymphoma
[Protocol 13-180]
Horwitz, Steven
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Armodafinil versus Placebo to Reduce Cancer-Related Fatigue in Patients with High-Grade Glioma
Newly Diagnosed & Relapsed/Refractory
[Protocol 14-040]
Diamond, Eli
  • Brain Tumors, Primary
    • Gliomas
  • Quality of Life
A Phase III Study of ARN-509 versus Placebo in Men with Non-Metastatic Castration-Resistant Prostate Cancer
[Protocol 13-243]
Rathkopf, Dana
  • Prostate Cancer
    • Rising PSA After Primary Therapy
A Phase III Study of Bendamustine and Rituximab plus GS-1101 (CAL-101) or Placebo for Previously Treated Chronic Lymphocytic Leukemia
[Protocol 12-189]
Zelenetz, Andrew
  • Leukemia
    • Chronic Lymphocytic Leukemia
A Phase III Study of Bendamustine and Rituximab with or without Ibrutinib in Older Patients with Newly Diagnosed Mantle Cell Lymphoma
[Protocol 13-196]
Hamlin, Paul
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of BKM120 with Fulvestrant in Postmenopausal Women with Locally Advanced or Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer
[Protocol 12-290]
Dickler, Maura
  • Breast Cancer
A Phase III Study of BMS-936558 (Nivolumab) versus Standard Chemotherapy in Patients with Advanced Melanoma that Progressed Despite Anti-CTLA-4 Therapy
[Protocol 12-254]
D'Angelo, Sandra
  • Melanoma
A Phase III Study of BMS-936558 versus Docetaxel in Previously Treated Advanced Squamous Cell Lung Cancer
[Protocol 12-203]
Rizvi, Naiyer
A Phase III Study of Brentuximab Vedotin plus CHP versus CHOP Therapy for Patients with Previously Untreated CD30-Positive Peripheral T-Cell Lymphoma
[Protocol 13-055]
Horwitz, Steven
  • Lymphoma
    • Non-Hodgkin's Lymphoma